期刊文献+

检测抗核包膜蛋白抗体的临床意义初探 被引量:1

The clinical significance of anti-nuclear envelope protein autoantibodies
原文传递
导出
摘要 目的进一步探讨抗核包膜蛋白抗体的临床意义。方法对48例原发性胆汁性肝硬化(PBC)及1881例对照组血清标本以间接免疫荧光法检测抗核抗体(ANA),选择抗核包膜蛋白抗体阳性的病例进行临床回顾性分析。结果1929例血清标本中50例抗核包膜蛋白抗体阳性,相关疾病包括PBC等多种系统性自身免疫病。抗核包膜蛋白抗体在PBC患者组中的阳性率为39.58%,明显高于其他系统性自身免疫性疾病组(x^2=134,P〈0.01)及非自身免疫性肝脏疾病组即;109,P〈0.01),诊断PBC的特异性为98.35%。结论抗核包膜蛋白抗体与多种疾病相关,这种现象可能与其靶抗原的异质性相关。但其对诊断PBC价值较高。 Objective To further investigate the clinical significance of anti-nuclear envelope protein autoantibodies. Methods Serum samples of 48 primary biliary cirrhosis (PBC) and 1881 control cases were screened for anti-nuclear antigens (ANA) by indirect immunofluorescence (IIF). Patients selected positive with anti-nuclear envelope protein autoantibodies were clinically retrospoctively reviewed. Results Fifty of the 1929 ANA positive cases detected ANA were positive for anti-nuclear envelope pi'otein autoantibodies. The autoantibodies could exist in many kinds of diseases, including PBC, and various systemic autoimmune diseases. Prevalence of the autoantibodies in PBC patients was 39.58%, which was significantly higher than that in other systemic autoimmune diseases patients (x^2=-134, P〈0.01 ) and other liver diseases patients (x^2=-109, P〈 0.01), and their specificity for PBC was 98.35%. Conclusion Anti-nuclear envelope protein autoantibodies are associated with various diseases, which may be related with its various target antigens. It has important implication for clinical diagnosis of PBC.
出处 《中华风湿病学杂志》 CAS CSCD 2007年第1期27-30,共4页 Chinese Journal of Rheumatology
关键词 肝硬化 胆汁性 自身免疫疾病 抗核包膜蛋白抗体 间接免疫荧光法 Liver cirrhosis, biliary Autoimmune disease Anti-nuclear envelope protein autoanti- bodies Indirect immunofluorescence
  • 相关文献

参考文献13

  • 1Nesher G,Margalit R,Ashkenazi YJ.Anti-nuclear envelope antibodies:clinical associations.Semin Arthritis Rheum,2001,30:312-320. 被引量:1
  • 2Heathcote EJ.Management of primary biliary cirrhosis:the American association for the study of liver diseases practice guidelines.Hepatology,2000,31:1005-1013. 被引量:1
  • 3Bradwell AR,Stockes RP,Johnson CD,et al.Atlas of HEp-2 Patterns and Laboratory Technique.London:KNP Group Ltd,1995. 被引量:1
  • 4Andrea R,Krapt-Carlos A,von Muehlen A,et al.Altas of immunofluorescent autoantibodies.Baltimore:Printed by Digi Pruck,1996. 被引量:1
  • 5Senecal JL,Ichiki S,Girard D,et al.Autoantibodies to nuclear lamins and to intermediate filament protein:natural,pathologic or pathogenic.J Rheumatol,1993,20:211-219. 被引量:1
  • 6Enarson P,Rattner JB,Ou Y,et al.Autoantigens of the nuclear pore complex.J Mol Med,2004,82:423-433. 被引量:1
  • 7Nishikai M,Tomomatsu S,Hankins RW,et al Autoantibodies to a 68/48 kDa protein in chronic fatigue syndrome and primary fibromyalgia:a possible marker for hypersomnia and cognitive disorders.Rheumatology (Oxford),2001,40:806-810. 被引量:1
  • 8Konstantinov K,yon Mikecz A,Buchwald D,et al.Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome.J Clin Invest,1996,98:1888-1896. 被引量:1
  • 9Miyachi K,Hankins RW,Matsushima H,et al.Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis:a multicenter study.J Autoimmun,2003,20:247-254. 被引量:1
  • 10Lin F,Noyer CM,Ye Q,et al.Autoantibodies from patients with primary biliary cirrhosis recognize a region within the nucleoplasmic domain of inner nuclear membrane protein LBR.Hepatology,1996,23:57-61. 被引量:1

同被引文献13

  • 1Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the study of liver diseases practice guidelines. Hepatology, 2000, 31: 1005-1013. 被引量:1
  • 2Worman HJ, Courvalin JC. Antinuclear antibodies specific for primary biliary cirrhosis. Autoimmun Rev, 2003, 2:211-217. 被引量:1
  • 3Muratori P, Muratori L, Ferrari R, et al. Characterization and clinical impact of antintlclear antibodies in primary biliary cirrhosis. Am J Gastroenlerol, 2003, 98: 431-437. 被引量:1
  • 4Itoh S, Ichida T, Yoshida T, et al. Autoantibodies against a 210 kDa glycoprotein of the nuclearpore complex as a prognostic marker in patients with primary biliary cirrhosis. J Gastroenterol Hepatol, 1998, 13: 257-265. 被引量:1
  • 5Nakamura M, Shimizu-Yoshida Y, Takii Y, et al. Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis. J Hepatol, 2005, 42: 386-392. 被引量:1
  • 6Invcrnizzi P, Podda M, Battezzati PM, et al. Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol, 2001, 34: 366-372. 被引量:1
  • 7Nakamura M, Kondo H, Mori T, et al. Anti-gp210 and anti-eentromere antibodies are different risk factors for the progression of. primary biliary cirrhosis. Hepatology, 2007, 45:118-127. 被引量:1
  • 8Greber UF, Senior A. Gerace L. A major glycoprotein of the nuclear pore complex is a membrane-spanning polypeptide with a large lumenal domain and a small cytoplasmic tail. EMBO J,1990, 9: 1495-502. 被引量:1
  • 9Wozniak RW, Bartnik E, Blobel G. Primary. structure analysis of an integral membrane glycoprotein of the nuclear pore. J Cell Biol, 1989, 108: 2083-2092. 被引量:1
  • 10Bandin O, Courvalin JC, Poupon R, et al. Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis. Hepatology, 1996, 23: 1020-1024. 被引量:1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部